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ABSTRACT
In epidemiologic studies, the relationship between fish consumption and the metabolic syn-
drome (MetS) have been inconclusive and sex differences reported. The aim was to investigate
associations between fish intake and the MetS in a cross-sectional study of men and women. Fish
intake, waist circumference, triglycerides (TG), HDL-C, glucose and blood pressure were assessed
among 2874 men and women (46–49 y) in the Hordaland Health Study (1997–1999). Fatty fish
intake was inversely associated with TG in men only; mean difference in TG between highest and
lowest quartile of fatty fish intake was –0.33 mmol/L (95% CI: –0.51, –0.15). Lean fish intake was
inversely associated with TG in women only; mean difference in TG between highest and lowest
quartile of lean fish intake was –0.23 mmol/L (95% CI: –0.34, –0.11). Fatty fish intake was positively
associated with serum HDL-C in both men and women. Total fish intake was inversely associated
with MetS; adjusted OR 0.75 (95% CI 0.57, 0.97). Higher fish intake was associated with lower odds
of having MetS possibly driven by associations of higher fish intake with lower TG and higher
HDL-C. The findings of differential associations by sex needs to be confirmed and possible
biologic mechanisms explored.
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Introduction
Themetabolic syndrome (MetS) is a cluster of risk factors
related to increased risk of cardiovascular disease and
type 2 diabetes mellitus. Several diagnostic criteria exist,
but all tend to agree on the inclusion of abdominal obesity
(elevated waist circumference (WC)), hyperglycemia, ele-
vated triglycerides (TG), low levels of high density lipo-
protein cholesterol (HDL-C), and hypertension [1]. The
prevalence of MetS is dependent on definition used and
population studied. Prevalence estimates differ across sex,
age, and ethnicity, as well as lifestyle habits and socio-
economic status [1]. In a population-based survey in
Norway, the estimated prevalence of MetS in 1995–1997
was 27.6 and 21.8% in men and women (40–49 years),
respectively [2]. The prevalence of the different MetS
components was, except for central obesity, higher in
men than women [2]. A healthy lifestyle, including diet
and physical activity, is important for preventing and
treating components of MetS [1].
Supplementation with the omega-3 (n-3) long-chain
polyunsaturated fatty acids (LC-PUFA) eicosapentae-
noic acid (EPA) and docosahexaenoic acid (DHA)
reduces circulating TG and may have a small effect
on increasing HDL-C [3]. Fish is the main dietary
source of EPA and DHA but habitual fish consumption
generally provides considerably lower amounts of these
fatty acids than usually distributed in studies using n-3
LC-PUFA supplementation. Moreover, other nutrients
in fish besides n-3 LC-PUFA may also affect compo-
nents of MetS. Fish consumption contributes to dietary
intake of selenium, vitamin D, protein, choline, and
vitamin B12 and it is therefore important to explore not
only specific nutrients but fish consumed.
In epidemiologic studies, the relationship between
fish consumption and prevalence of MetS has shown
either no association [4,5] or an inverse association
[6,7]. Higher fish intake has been associated with
lower TG and higher HDL-C [6,8,9]. However, most
epidemiologic studies have focused on the association
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of total fish intake whereas very few have investigated
associations of different types of fish consumed and
MetS [9,10], which would provide additional informa-
tion. An investigation including different types of fish
intake requires that overall fish consumption is high
enough to create sub-groups of fish intake. Fish intake
in Norway is among the highest in Europe and a
Norwegian cohort should therefore be well suited for
studying sub-groups of fish [11]. Furthermore, one
prospective study and one cross-sectional study relat-
ing fish intake with MetS reported an inverse associa-
tion in men but no association in women [12,13].
Overall, considering sex differences in studies of diet
and MetS is of importance. The aim of the current
study was to investigate the association between intake
of fish (total fish consumption as well as type of fish
consumed) and MetS and its components in middle-
aged men and women with habitually high fish con-




The current investigation is a cross-sectional study
among participants from the Hordaland Health Study
(HUSK). HUSK was conducted during 1997–1999 as
collaboration between the University of Bergen, the
National Health Screening Service (now the Norwegian
Institute of Public Health), and local health services.
Extensive information of the study can be found at
http://husk.b.uib.no. All participants signed an informed
consent. The study protocol was in accordance with
principles of the Declaration of Helsinki and the study
was approved by the Regional Committee for Medical
and Health Research Ethics.
In the current study, 3723 participants born 1950–
1951 (age 46–49 years) who answered a food frequency
questionnaire (FFQ) were included. Subjects who
reported a very low (<3000 kJ/day for women and
<3300 kJ/day for men) or high (>15,000 kJ/day for
women and >17,500 kJ/day for men) energy intake
were excluded (n = 78). In addition, patients with miss-
ing measures of MetS components or high-sensitivity
C-reactive protein (CRP) (n = 165) were excluded leav-
ing a total of 1225 men and 1649 women for the current
analysis.
Dietary assessment
A 169-item semi-quantitative FFQ developed at the
Department of Nutrition, University of Oslo, Norway
was used to estimate habitual dietary intake during the
last year [14–16]. The FFQ was handed out on the day of
the health examination, filled out at home, and returned
by mail to the HUSK project center. Daily food (grams
per day) and nutrient intakes (including supplements)
were calculated using a database and software system
developed at the Department of Nutrition, University of
Oslo (Kostberegningssystem, version 3.2; University of
Oslo, Norway). The food database was mainly based on
the Norwegian food composition table, with some addi-
tional foods [17].
Items in the FFQ related to fish consumption
included fish as spread (sandwich meals are common
in Norway) or fish as part of main meals. Questions
related to fish as spread were: How many slices of bread
with the following spread do you eat per week; tinned
mackerel in tomato paste or smoked mackerel; sardines;
pickled herring; anchovies or similar fish; salmon or
trout; and sandwich caviar. These questions included
11 frequency categories which ranged from 0 to ≥36
slices/week. Questions on fish intake as part of main
meals included the following: fish cakes, fish pudding
and fish balls (fish mixed with milk, flour and/or egg);
fish fingers; boiled cod, coalfish and haddock; fried cod,
coalfish and haddock; fresh, salt-cured or smoked her-
ring; fresh or smoked mackerel; salmon or trout (both
wild and farmed); and fish stew, fish soup and fish au
gratin. The questions were two-fold and included nine
frequency categories (0 to ≥9 times/month) and five
portion size categories (piece, fillet, slice, or household
measures depending on question). In the current analy-
sis, the following categories of fish intake were con-
structed: ‘total fish’ (lean, fatty, unspecified fish as part
of main meal, fish products, and fish as spread), ‘lean
fish’ (cod, coalfish, or haddock as part of main meal),
‘fatty fish’ (mackerel, herring, trout, or salmon as part of
main meal and fish as spread which included mackerel,
salmon, trout, sardines, pickled herring, or sandwich
caviar), and ‘fish products’ (fish fingers, fish pudding,
fish cakes, etc.). For daily total marine n-3 LC-PUFA
intake (diet and supplements), we used the sum of EPA,
docosapentaenoic acid (DPA), and DHA. Participants
reporting use of supplemental cod liver oil or fish oil
were defined as users of such. Adjustment for total
energy intake was performed using the multivariate
nutrient density method, either as g/1000 kcal (foods)
or as percent of total energy intake (macronutri-
ents) [18].
MetS definition
MetS was defined by criteria from the Joint Interim
Societies using population specific cut-off for WC










































[19]. The cut-offs were as follow: WC ≥94 cm in men
and ≥80 cm in women (Europid population); TG
≥1.7 mmol/L; HDL-C < 1.0 mmol/L in
men and <1.3 mmol/L in women; elevated systolic
blood pressure (SBP) ≥130 and/or diastolic
blood pressure (DBP) ≥85 mmHg; elevated fasting
glucose ≥5.5 mmol/L (serum glucose in this study
was non-fasting). The presence of any three of these
five factors constitutes a diagnosis of MetS.
Biochemical data
Non-fasting blood samples were collected. Serum sam-
ples of total cholesterol, HDL-C, TG, and glucose were
analyzed within 7 days at the department of Clinical
Chemistry, Ullevål University Hospital, Oslo, using enzy-
matic methods with reagents from Boehringer
Mannheim (Roche, Basel, Switzerland). Non-HDL-C
was calculated as the difference between total cholesterol
and HDL-C. Cotinine (biomarker of recent nicotine use)
and CRP were measured in EDTA plasma stored at −80°
C until analyzed at Bevital A/S (www.bevital.no) by LC/
MS/MS and MALDI-TOF MS, respectively.
Clinical data
Participants had a brief health examination including
measurement of blood pressure, height, weight, and
WC. After a 10 min seated rest, SBP and DBP were
measured three times and the mean value of the
second and third measurements was used (Dinamap
845 XT equipment (Criticon). In a sub-sample, body
composition was measured by dual energy X-ray
absorptiometry (Expert-XL; Lunar Company Inc.,
Madison, US). Information on educational level,
medication use, smoking, and physical activity was
collected through self-administered questionnaires.
Participants answered two questions of leisure time
physical activity referring to heavy physical activity
(sweating and getting out of breath) or light physical
activity (e.g. walking, gardening, housework with no
sweating, or getting out of breath) in the past year
(none, < 1 h/wk, 1–2 h/wk, or ≥3 h/wk). As pre-
viously described [20], categories for light physical
activity were replaced with a value of 0 (none), 0.25
(<1 h/wk), 0.5 (1–2 h/wk), or 1.0 (≥3 h/wk) and for
hard physical activity with 0 (none), 0.5 (<1 h/wk),
1.0 (1–2 h/wk), or 2.0 (≥3 h/wk). The sum of these
scores was calculated and used in multivariate mod-
els. Current smokers were identified as participants
having cotinine concentrations ≥85 nmol/L. In case
of missing cotinine measures (n = 30) self-reported
smoking status was used.
Statistical analyses
Characteristics and daily dietary intake variables were
summarized using means ± SD or medians (5th, 95th
percentiles) for continuous variables and proportions
for categorical variables. Baseline characteristics and
dietary intake across quartiles of total fish intake were
evaluated by using linear regression for continuous
variables, logistic regression for binary variables, and
Pearson’s Chi-square test for categorical variables.
Differences between men and women were assessed
by the Mann–Whitney U or Fisher’s exact tests.
Intake of fish was categorized into quartiles based on
the total population with the lowest quartile as reference.
Associations between intake of fish and components of
MetS were assessed using multiple linear regression analy-
sis. Fish intake variables were represented in the multiple
linear regression models with indicator variables for each
of the three non-reference quartiles (quartiles 2–4).
Associations between intake of fish and prevalence of
MetS were evaluated using logistic regression. In themulti-
ple linear and logistic regression analyses, missing data
(educational level and physical activity) were accounted
for using multiple imputations. Confounders considered
were age, sex, smoking, physical activity, educational level,
estrogen use (women only) and dietary factors. Analyses
were performed excluding individuals currently using anti-
hypertensive medications. To explore any modifying
effects by sex, analyses were stratified and interactions
between fish intake and gender were tested by adding
interaction product terms (fish intake quartiles*sex) into
otherwise identical regression models. Due to non-fasting
blood samples, sensitivity analyses of associations between
fish intake and MetS were performed using an alternative
cut-off of ≥6.0 mmol/L for defining elevated glucose.
Statistical analyses were performed with SPSS for
Windows, version 22 (IBM, NY, USA). A two-sided
p-value <0.05 was considered statistically significant.
Results
Characteristics and dietary intake
Reported energy-adjusted total fish intake and absolute
total fish intake were (mean ± SD) 34.4 ± 19.1 g/1000
kcal/d and 72.9 ± 46.0 g/d, respectively. Non-consumption
(0 g/day) of total fish, lean fish, fatty fish, and fish products
was reported by 0.6, 6.1, 8.9, and 6.0%, respectively.
Compared with women, men were more likely to use
lipid-modulating or anti-hyperglycemic drugs, having
higher level of education, and to be overweight or obese
(Table 1). Mean concentrations of TG, total cholesterol,
CRP, SBP, and DBP were higher in men compared with










































women.Mean concentrations ofHDL-C and body fatmass
were higher in women than men (Table 1).
A higher proportion of men than women used supple-
mental cod liver oil, 38.0% versus 33.4%, respectively
(Table 2). Compared with men, women reported higher
intakes of fiber, fruit and berries, and vegetables. A higher
proportion of women compared with men reported con-
suming no alcohol. Energy-adjusted intake of total fish
and types of fish (g/1000 kcal) was similar in men and
women with only slightly higher lean fish intake in
women compared with men (Table 2). Reported absolute
intake (not adjusted for total energy intake) of total fish
and types of fish was higher in men compared with
women (data not shown).
Men and women with higher consumption of total fish
had a higher intake of protein, fiber, vegetables, fruit and
berries, and meat but a slightly lower intake of carbohy-
drates and SFA. Participants with higher intake of total fish
were more likely to use fish oil (Supplementary Tables 1
and 2). Characteristics across quartiles of energy-adjusted
total fish intake inmen andwomenwere explored. Inmen,
higher intake of total fish was positively associated with use
of lipid-modulating medications, BMI, WC and body fat
mass. There were no statistically significant associations
between total fish intake and current smoking, use of anti-
hypertensive or anti-hyperglycemic medications, physical
activity, educational level, or circulating CRP in men (data
not shown). In women, higher intake of total fish was
associated with lower level of education, lower serum TG
and higher HDL-C concentrations. There were no statisti-
cally significant associations between fish intake and cur-
rent smoking, use of lipid-modulating, antihypertensive or
anti-hyperglycemic medications, current estrogen therapy,
physical activity, or circulating CRP in women (data not
shown).
Blood measures were non-fasting and for 82.2% of the
subjects time since last meal was less than 4 h. Serum
glucose was inversely associated with time since last meal
(rho = −0.22, p < 0.001). TG were weakly inversely asso-
ciated with time since last meal (rho = −0.05, p < 0.01)
whereas HDL-C was not significantly associated with
time since last meal (rho = −0.01, p = 0.68).
Associations between intake of fish and MetS
components
Total cohort
There were no associations between fish intake and
SBP, DBP, or serum glucose (Table 3). Excluding
individuals using anti-hypertensive drugs did not
affect the results. In the total cohort, intake of fatty






n = 1649 p
Current smokers 35.9 35.8 36.0 0.94
Anti-hyperglycemic drugs 0.6 0.9 0.3 0.04
Antihypertensive drugs 5.3 5.4 5.2 0.80
Lipid-modulating drugs 2.2 3.3 1.3 <0.001
Estrogen therapy 18.3 NA 18.3 NA
Metabolic syndrome 30.0 37.3 24.6 <0.001
Educational level <0.001
Primary school <10 y 19.4 15.7 22.2
A-levels/high school 42.5 41.6 43.1
College/University 38.1 42.7 34.7
Hard physical activity <0.001
None 25.9 28.9 21.8
<1 h/wk 28.2 26.1 31.1
1–2 h/wk 31.6 32.6 30.4
≥3 h/wk 14.2 12.4 16.6
BMI (kg/m2) <0.001
<24.9 51.0 38.5 60.3
25.0–29.9 38.6 50.1 30.0
≥30.0 12.0 11.3 9.8
Waist circumference (cm) 85.5 ± 11.6 92.7 ± 8.9 80.2 ± 10.4 <0.001
Body fat mass (%) 32.0 ± 9.6 24.6 ± 7.4 36.6 ± 7.7 <0.001
Systolic blood pressure (mmHg) 127 ± 15 131 ± 14 124 ± 15 <0.001
Diastolic blood pressure (mmHg) 75 ± 11 78 ± 9.9 72 ± 10 <0.001
Serum triglycerides (mmol/L) 1.70 ± 1.09 2.06 ± 1.23 1.43 ± 0.89 <0.001
Serum total cholesterol (mmol/L) 5.73 ± 0.95 5.83 ± 0.98 5.65 ± 0.92 <0.001
Serum HDL-C (mmol/L) 1.33 ± 0.37 1.15 ± 0.30 1.45 ± 0.36 <0.001
Serum non-HDL-C (mmol/L) 4.40 ± 1.02 4.68 ± 1.02 4.19 ± 0.97 <0.001
Serum glucose (mmol/L) 5.2 ± 1.0 5.3 ± 1.1 5.1 ± 0.9 <0.001
C-reactive protein (mg/L), median (IQR) 1.07 (2.11) 1.12 (2.07) 1.01 (2.14) 0.04
Values represent percentages and means ± SD. Missing data: education n = 26, physical activity n = 112 and body fat mass n = 441. P values for differences
between men and women were calculated using Mann–Whitney U test or Fisher’s exact test for continuous and categorical variables, respectively. Blood
sampling in the Hordaland Health Study was non-fasting.










































fish was inversely associated with TG and positively
associated with HDL-C. Intake of lean fish was inver-
sely associated with WC and TG. Overall, additional
adjustment for educational level, physical activity, and
dietary intake did not alter the results materially.
Associations between fish intake and WC were
slightly attenuated in models controlling for educa-
tional level, physical activity and dietary intake but
remained statistically significant. Consumption of fish
products was not significantly associated with any of
the MetS components.
In men and women
We observed a significant interaction of gender for the
associations between fish intake and TG, both for lean
fish (pint = 0.05) and fatty fish (pint = 0.02) (Table 3). In
men, fatty fish was inversely associated with WC and TG
whereas intake of lean fish was inversely associated with
WC and TG in women (Table 4). Intake of fatty fish was
positively associatedwithHDL-C in bothmen andwomen.
In women, the association between fatty fish intake and
HDL-C was attenuated in the fully adjusted model, the
mean difference in serum HDL-C between highest and
lowest quartile was 0.04 mmol/L (95% CI: −0.00, 0.09,
p = 0.07). Further adjustment for use of estrogen did not
materially affect the results and is not included in the fully
adjustedmodels. Inmen, the association between total and
fatty fish intake andWCwas attenuated when adjusted for
educational level, physical activity and dietary intake.Mean
difference in WC between highest and lowest quartile of
total fish intake was −0.68 cm (95% CI: −1.46, 0.10,
p = 0.09). Mean difference in WC between highest and
lowest quartile of fatty fish intake was −0.61 cm
(95% CI: −1.38, 0.16, p = 0.12).
In post-hoc analysis, stratification on serum TG con-
centrations < or ≥1.7 mmol/L revealed an inverse associa-
tion between fatty fish intake and serum TG in men with
TG concentrations ≥1.7 mmol/L but not with TG concen-
trations <1.7 mmol/L (Supplementary Table 3). No such
patterns were found in women.
Association between fish intake and MetS
In the total cohort, 30% had MetS and the prevalence was
higher in men compared with women (Table 1). The pre-
valence of theMetS components in the total cohort were as
follows; elevated WC 46.3%, elevated TG 36.2%, reduced
HDL-C 34.3%, elevated blood pressure (SBP and/or DBP)






n = 1649 p
Energy (kcal) 2131 ± 625 2474 ± 615 1876 ± 496 <0.001
Carbohydrate (E%) 49.9 ± 5.9 49.5 ± 5.7 50.2 ± 6.0 <0.01
Fiber (g/1000 kcal) 11.8 ± 3.1 10.8 ± 2.6 12.5 ± 3.2 <0.001
Protein (E%) 16.1 ± 2.3 15.8 ± 2.2 16.3 ± 2.4 <0.001
Total fat (E%) 32.0 ± 5.1 32.1 ± 5.0 31.8 ± 5.2 0.16
SFA (E%) 12.3 ± 2.3 12.2 ± 2.3 12.4 ± 2.4 <0.01
MUFA (E%) 10.2 ± 1.8 10.3 ± 1.8 10.1 ± 1.8 0.01
PUFA (E%) 6.9 ± 2.0 7.1 ± 2.0 6.8 ± 2.0 <0.001
n-3 PUFA (E%)a 1.2 ± 0.4 1.2 ± 0.4 1.2 ± 0.4 0.03
n-3 LC-PUFA (E%)b 0.4 ± 0.3 0.4 ± 0.3 0.4 ± 0.4 0.39
n-6 PUFA (E%)c 5.6 ± 1.8 5.8 ± 1.8 5.5 ± 1.7 <0.001
Alcohold (%) <0.001
None 15.6 9.2 20.3
Low-moderate 72.7 79.9 67.3
Moderate 8.8 6.9 10.2
High 3.0 3.9 2.2
Supplement use (%)
Fish oil use 8.0 7.8 8.2 0.73
Cod liver oil use 35.4 38.0 33.4 0.01
Food intake
Vegetables (g/1000 kcal) 103 ± 74.1 78.8 ± 60.1 122 ± 78.1 <0.001
Fruit and berries (g/1000 kcal) 119 ± 78.6 96.7 ± 64.2 136 ± 84.0 <0.001
Meat (g/1000 kcal) 56.6 ± 23.2 57.3 ± 23.0 56.0 ± 23.3 0.09
Dairy products (g/1000 kcal) 145 ± 6.9 157 ± 104 136 ± 101 <0.001
Total fish (g/1000 kcal) 34.4 ± 19.1 33.6 ± 19.0 35.0 ± 19.2 0.04
Fatty fish (g/1000 kcal) 10.2 ± 10.3 10.6 ± 10.6 9.8 ± 10.1 0.07
Lean fish (g/1000 kcal) 13.0 ± 11.0 12.2 ± 10.6 13.6 ± 11.3 <0.001
Fish products (g/1000 kcal) 8.0 ± 5.9 8.0 ± 5.7 8.0 ± 6.0 0.52
Values represent percentages and means ± SD. P values for differences between men and women were calculated using Mann–Whitney U test or Fisher’s
exact test for continuous and categorical variables, respectively. E%, percent of total energy intake, LC-PUFA, long-chain polyunsaturated fatty acid; MUFA,
monounsaturated fatty acid; n-3, omega-3; n-6, omega-6; SFA, saturated fatty acid.
a Sum of α-linolenic acid, eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid.
b Sum of eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid.
c Sum of linoleic acid and arachidonic acid.
dNone: 0 g/day; Low-moderate: women 0.1–10 g/day, men 0.1–20 g/day; Moderate: women 10–20 g/d, men 20–30 g/d; High: women >20 g/day, men >30 g/day.










































41.4%, and elevated glucose (non-fasting) 21.5%. When
using cut-off ≥6.0 mmol/L instead of ≥5.0 mmol/L for
defining elevated glucose (non-fasting), the prevalence of
elevated glucose and MetS was 13.2% and 27.3%,
respectively.
Higher intakes of total and fatty fish were inversely
associated with the MetS (Table 5). After adjustment for
educational level, physical activity, and dietary intake,
higher fatty fish intake was no longer significantly asso-
ciated withMetS; fully adjusted (model 2) OR (95%CI) for
highest vs. lowest quartile was 0.79 (0.61, 1.02), p = 0.08).
Intake of fish products was not associated with having
MetS. There were no statistically significant interactions
between fish intake and sex besides a tendency towards an
interaction between lean fish intake and sex (Table 5). In
women, a high intake (fourth quartile) of lean fish was
inversely associated with MetS; fully adjusted (Model 2)
OR (95% CI) for highest vs. lowest quartile was 0.63 (0.44,
0.92), p = 0.02 (p for trend = 0.06). Lean fish intake was not
associated with MetS in men. Sensitivity analyses of asso-
ciations between fish intake and MetS, using cut-




In this cross-sectional study including middle-aged men
and women, high fish intake was associated with lower
circulating TG and higher HDL-C. Notably, there were
sex differences showing differential associations between
type of fish consumed and serum TG. Reported intake
of fatty fish was inversely associated with TG in men
only, whereas higher lean fish intake was inversely asso-
ciated with TG in women. Fatty but not lean fish con-
sumption was positively associated with HDL-C in both
men and women. High intake of total fish was inversely
associated with MetS without clear evidence of differ-
ences by sex or type of fish consumed.
Fish intake and MetS
Associations of fish consumption with MetS and
its components have been investigated in both cross-
sectional and prospective cohort studies. The observed
inverse association between intake of fish and circulating
TG and the positive association with HDL-C in the
Table 3. Mean differences in components of the metabolic syndrome by quartiles of daily fish intake in reference to quartile one in
2874 men and women (46–49 years).





Model 2 p interaction
Total fish (g/1000 kcal) 26.4 (22.1, 31.0)a 36.7 (32.2, 43.2) 54.5 (44.7, 94.5)
Waist circumference (cm) −0.19 (−0.71, 0.33) −0.32 (−0.84, 0.20) −0.65 (−1.17, −0.13) 0.01 0.04 0.54
Triglycerides (mmol/L) −0.04 (−0.14, 0.07) −0.10 (−0.20, 0.01) −0.18 (−0.28, −0.08) <0.001 <0.01 0.58
HDL-C (mmol/L) 0.03 (−0.00, 0.06) 0.04 (0.00, 0.07) 0.06 (0.02, 0.09) <0.001 <0.01 0.35
Systolic blood pressure (mmHg) −0.70 (−2.18, 0.78) 0.21 (−1.27, 1.69) 0.90 (−0.58, 2.38) 0.13 0.20 0.64
Diastolic blood pressure (mmHg) −0.21 (−1.24, 0.83) 0.06 (−0.97, 1.10) −0.16 (−1.20, 0.87) 0.90 0.71 0.87
Glucose (mmol/L) 0.01 (−0.12, 0.09) −0.05 (−0.15, 0.06) 0.02 (−0.08, 0.13) 0.83 0.90 0.72
Lean fish (g/1000 kcal) 8.3 (5.8, 10.6)a 13.9 (11.2, 17.4) 23.9 (18.2, 48.4)
Waist circumference (cm) −0.28 (−0.80, 0.24) −0.23 (−0.75, 0.29) −0.75 (−1.27, −0.23) <0.01 0.04 0.10
Triglycerides (mmol/L) −0.04 (−0.14, 0.07) −0.07 (−0.17, 0.03) −0.11 (−0.22, −0.01) 0.03 0.03 0.05
HDL-C (mmol/L) 0.01 (−0.03, 0.04) −0.01 (−0.04, 0.03) 0.00 (−0.03, 0.03) 0.79 0.63 0.15
Systolic blood pressure (mmHg) −0.22 (−1.70, 1.26) 1.78 (0.30, 3.26) 0.58 (−0.90, 2.06) 0.12 0.19 0.29
Diastolic blood pressure (mmHg) 0.29 (−0.75, 1.32) 0.55 (−0.48, 1.58) 0.00 (−1.03, 1.04) 0.87 0.98 0.45
Glucose (mmol/L) −0.06 (−0.17, 0.04) 0.04 (−0.06, 0.15) −0.01 (−0.12, 0.09) 0.70 0.96 0.56
Fatty fish (g/1000 kcal) 5.2 (3.4, 7.3)a 10.4 (7.9, 13.5) 19.9 (14.2, 46.7)
Waist circumference (cm) −0.21 (−0.73, 0.31) −0.66 (−1.18, −0.14) −0.35 (−0.87, 0.18) 0.08 0.13 0.06
Triglycerides (mmol/L) −0.08 (−0.18, 0.02) −0.10 (−0.20, 0.00) −0.18 (−0.28, −0.07) <0.001 <0.01 0.02
HDL-C (mmol/L) 0.04 (0.01, 0.07) 0.06 (0.03, 0.09) 0.08 (0.05, 0.11) <0.001 <0.001 0.73
Systolic blood pressure (mmHg) 0.46 (−1.02, 1.94) 0.02 (−1.47, 1.49) 1.26 (−0.22, 2.75) 0.16 0.26 0.47
Diastolic blood pressure (mmHg) 0.16 (−0.87, 1.20) −0.54 (−1.57, 0.50) 0.47 (−0.57, 1.50) 0.68 0.94 0.92
Glucose (mmol/L) −0.02 (−0.12, 0.09) −0.01 (−0.11, 0.09) 0.01 (−0.09, 0.12) 0.77 0.98 0.24
Fish products 5.6 (4.0, 7.0)a 8.9 (7.3, 10.9) 14.4 (11.5, 25.1)
Waist circumference (cm) −0.19 (−0.72, 0.33) −0.35 (−0.87, 0.17) −0.31 (−0.83, 0.21) 0.19 0.25 0.87
Triglycerides (mmol/L) 0.01 (−0.09, 0.12) −0.09 (−0.19, 0.02) −0.02 (−0.12, 0.08) 0.32 0.37 0.87
HDL-C (mmol/L) −0.01 (−0.04, 0.02) 0.00 (−0.03, 0.03) 0.00 (−0.03, 0.03) 0.81 0.59 0.43
Systolic blood pressure (mmHg) 0.73 (−0.76, 2.22) 1.05 (−0.44, 2.53) 0.64 (−0.84, 2.12) 0.35 0.30 0.05
Diastolic blood pressure (mmHg) 0.36 (−0.68, 1.40) 0.28 (−0.76, 1.32) 0.15 (−0.88, 1.19) 0.82 0.64 0.36
Glucose (mmol/L) −0.07 (−0.17, 0.04) −0.09 (−0.20, 0.01) 0.00 (−0.10, 0.11) 0.93 0.98 0.70
Multiple linear regression was performed with all independent variables included in the model simultaneously (Model 1: energy intake, sex, BMI, and
smoking; Model 2: energy intake, sex, BMI, smoking, educational level, physical activity, alcohol consumption, fiber intake, and vegetable intake). The
unstandardized B coefficients (95% CI) from Model 1 are presented. P for trend was calculated using quartiles as a continuous variable in otherwise
identical multiple linear regression models. P for interaction was evaluated by including the product term fish intake quartiles*sex in multivariate Model 1.
Blood sampling in the Hordaland Health Study was non-fasting.
a Median (5th, 95th percentiles), n = 718–719 per quartile.










































current study is largely in accordance with other studies.
However, in contrast to us, most of these studies inves-
tigated intake of total fish only. Examining type of fish
consumed in addition to total fish adds information
when exploring the fish–MetS relationship. In the cur-
rent study, both fatty and lean fish intake was inversely
associated with serum TG, however, with differential
associations in men and women. In a prospective cohort
among Korean men and women (40–69 years), daily
total fish consumption in comparison to less than once
a week was associated with lower incidence of high
serum TG in men but not women [12]. In an Iranian
cross-sectional study including only women, higher total
fish intake (tertile three vs. tertile one) was inversely
associated with hypertriglyceridemia and low HDL-C
levels [6]. Moreover, in the CARDIA study including
young American men and women (18–30 years), higher
total non-fried fish consumption was associated with
lower incidence of abnormal TG and HDL-C [8]. In a
Norwegian cross-sectional study, fatty fish intake was
inversely associated with serum TG in both men and
women whereas lean fish intake was positively asso-
ciated with HDL-C in men only [10]. In intervention
trials, the groups receiving fatty fish have decreased
circulating TG [21,22], whereas groups receiving lean
fish have in some [23] but not all [24–26] decreased TG.
Table 4. Mean differences in waist circumference, triglycerides, and HDL-C by quartiles of fish intake in reference to quartile one in
1225 men and 1649 women (46–49 years).







Total fish (g/1000 kcal) 26.4 (22.0, 30.9)a 36.2 (32.3, 43.2) 54.2 (44.7, 97.4)
Waist circumference (cm) −0.27 (−1.02, 0.49) −0.49 (−1.26, 0.27) −0.87 (−1.64, −0.10) 0.02 0.08
Triglycerides (mmol/L) −0.08 (−0.26, 0.10) −0.06 (−0.24, 0.13) −0.21 (−0.39, −0.02) 0.05 0.06
HDL-C (mmol/L) 0.03 (−0.01, 0.08) 0.01 (−0.03, 0.06) 0.05 (0.00, 0.09) 0.10 0.14
Lean fish (g/1000 kcal) 8.4 (5.7, 10.6)a 13.8 (11.1, 17.5) 24.3 (18.2, 45.5)
Waist circumference (cm) 0.05 (−0.70, 0.79) −0.02 (−0.78, 0.73) −0.57 (−1.34, 0.21) 0.18 0.27
Triglycerides (mmol/L) 0.04 (−0.14, 0.22) −0.07 (−0.25, 0.11) 0.02 (−0.16, 0.21) 0.87 0.86
HDL-C (mmol/L) −0.01 (−0.05, 0.04) −0.05 (−0.09, 0.00) −0.02 (−0.07, 0.02) 0.13 0.11
Fatty fish (g/1000 kcal) 5.3 (3.3, 7.3)a 10.5 (7.9, 13.5) 19.7 (14.2, 49.2)
Waist circumference (cm) −0.15 (−0.93, 0.63) −1.19 (−1.97, −0.42) −0.74 (−1.51, 0.02) <0.01 0.03
Triglycerides (mmol/L) −0.14 (−0.33, 0.05) −0.23 (−0.42, −0.05) −0.33 (−0.51, −0.15) <0.001 <0.001
HDL-C (mmol/L) 0.04 (−0.01, 0.08) 0.05 (0.01, 0.10) 0.09 (0.04, 0.13) <0.001 <0.001
Women
Total fish (g/1000 kcal) 26.4 (22.1, 31.1)a 36.8 (32.1, 43.2) 55.4 (44.7, 94.4)
Waist circumference (cm) −0.14 (−0.85, 0.58) −0.18 (−0.89, 0.53) −0.50 (−1.20, 0.21) 0.18 0.23
Triglycerides (mmol/L) −0.02 (−0.13, 0.10) −0.13 (−0.25, −0.02) −0.18 (−0.29, −0.07) <0.001 <0.001
HDL-C (mmol/L) 0.03 (−0.02, 0.08) 0.05 (0.01, 0.10) 0.06 (0.02, 0.11) <0.01 0.05
Lean fish (g/1000 kcal) 8.2 (5.8, 10.7)a 14.0 (11.2, 17.4) 23.6 (18.2, 49.3)
Waist circumference (cm) −0.53 (−1.26, 0.19) −0.40 (−1.11, 0.31) −0.91 (−1.16, −0.20) 0.02 0.03
Triglycerides (mmol/L) −0.11 (−0.22, 0.01) −0.08 (−0.19, 0.04) −0.23 (−0.34, −0.11) <0.001 <0.001
HDL-C (mmol/L) 0.02 (−0.03, 0.06) 0.02 (−0.03, 0.07) 0.02 (−0.03, 0.06) 0.48 0.60
Fatty fish (g/1000 kcal) 5.1 (3.4, 7.3)a 10.4 (7.9, 13.4) 20.0 (14.2, 43.8)
Waist circumference (cm) −0.26 (−0.95, 0.44) −0.27 (−0.97, 0.43) −0.04 (−0.75, 0.67) 0.89 0.92
Triglycerides (mmol/L) −0.03 (−0.14, 0.08) −0.00 (−0.11, 0.11) −0.07 (−0.19, 0.04) 0.32 0.46
HDL-C (mmol/L) 0.05 (0.00, 0.09) 0.06 (0.02, 0.11) 0.07 (0.03, 0.12) <0.01 0.07
Multiple linear regression was performed with all independent variables included in the model simultaneously (Model 1: energy intake, BMI, and smoking;
Model 2: energy intake, BMI, smoking, educational level, physical activity, alcohol consumption, fiber intake, vegetable intake and use of fish oil and/or cod
liver oil). The unstandardized B coefficients (95% CI) from Model 1 are presented. P for trend was calculated using quartiles as a continuous variable in
otherwise identical multiple linear regression models. Blood sampling in the Hordaland Health Study was non-fasting.
aMedian (5th, 95thpercentiles).
Table 5. Odds ratio (95% CIs) for metabolic syndrome prevalence per quartile of fish intake in 2874 men and women (46–49 years)a.
Quartiles of fish intake




Model 2 p interaction
Total fish 1.00 0.92 (0.72, 1.19) 0.85 (0.66, 1.09) 0.72 (0.56, 0.93) <0.01 0.03 0.14
Lean fish 1.00 0.96 (0.74, 1.24) 1.08 (0.84, 1.39) 0.81 (0.63, 1.06) 0.25 0.38 0.08
Fatty fish 1.00 0.90 (0.70, 1.17) 0.86 (0.67, 1.12) 0.76 (0.59, 0.99) 0.04 0.08 0.22
Fish products 1.00 0.95 (0.74, 1.23) 0.86 (0.67, 1.12) 0.91 (0.70, 1.17) 0.34 0.39 0.39
aLogistic regression was performed with all independent variables included in the model simultaneously (Model 1: energy intake, sex, BMI, and smoking;
Model 2: energy intake, sex, BMI, smoking, educational level, physical activity, alcohol consumption, fiber intake, and vegetable intake). Results are
presented as OR (95% CIs). p for trend was calculated using quartiles as a continuous variable in otherwise identical logistic regression models.










































However, type of fish, overall dietary intake, study popu-
lation and choice of control diets differ considerably
between the studies.
We observed an inverse association between intake
of fish and WC; however, considering the small effect
size and possible inaccuracies in measuring WC, our
findings may be of limited clinical relevance [27]. In
accordance with our findings, other epidemiologic stu-
dies also report no or only modest associations between
fish intake and elevated WC [8,9,12] or an increase in
WC over time [28]. Our findings of no significant
associations between fish intake (neither total nor
types of fish) and SBP, DBP, or glucose are in line
with results from other epidemiologic studies showing
no [8,9,12,29] or only modest associations [9].
Possible mechanisms
Findings from the present study are biologically plau-
sible. Fish, particularly fatty fish, is the major dietary
source of the n-3 LC-PUFAs EPA and DHA, and the
TG lowering effects of EPA and DHA are well docu-
mented [30,31]. The proposed mechanisms, although
not fully understood, are decreased availability of free
fatty acids, competitive inhibition of acyl-CoA:1,2-dia-
cylglycerol acyltransferase, suppression of lipogenic
genes, induction of fatty oxidation genes and increased
lipolytic activity of lipoprotein lipase in extrahepatic
tissues [3,32]. The effects of n-3 LC-PUFA on circulat-
ing HDL-C are less certain and usually smaller, and the
evidence is inconsistent [3]. Historically, health bene-
fits of increased fish consumption have been credited
its content of n-3 LC-PUFA, but fish intake also con-
tributes with considerable amounts of other nutrients
such as protein, vitamin D, B-vitamins, iodine, and
selenium. Protein from fish has been proposed, primar-
ily based on studies in animals, to have a beneficial
effect on lipid metabolism [33]. The evidence in
humans is, however, limited, with two intervention
studies reporting no effect of isolated cod protein on
circulating TG and HDL-C [34,35]. Vitamin D status
(25-hydroxyvitamin D) has been inversely associated
with MetS and its components [36] but there is limited
evidence from vitamin D supplementation trials on the
effects on serum lipids [37,38]. Thus, the higher intake
of n-3 LC-PUFA with higher fish consumption may
well be the most important explanatory factor, but
additional effects of other nutrients present in fish
cannot be excluded and may explain the associations
of lean fish intake.
Importantly, the intake of fish will replace other
foods and depending on food replaced this will affect
associations between fish consumption and MetS and
its components. Fish usually replaces meat and higher
meat consumption has been associated with increased
risk of having MetS [7,39]. In addition, meals including
fish may include other side dishes compared with
meals including meat which would further affect over-
all dietary intake [40].
Sex differences
We observed different associations for men and women
regarding type of fish consumed in relation to serum TG.
Fatty fish intake was inversely associated with TG in men
but not women, whereas lean fish intake was inversely
associated with TG in women only. To the best of our
knowledge, only two cross-sectional studies in addition to
ours, have evaluated lean and fatty fish intake separately
in relation to TG by sex. In contrast to our observations,
Torris et al. presented opposite associations in a popula-
tion study in Northern Norway in 1994–1995
(the Tromsø 4 study) [9]. Higher intake of lean fish was
associated with lower TG in men but not in women
(models adjusted for age and total energy intake) [9].
The population in the Tromsø study is seemingly similar
to ours; same country and time of observation, and with
presumably similar fish consumption regarding type of
fish [9]. However, the range of age for individuals
included was larger (26–70 years) and adjustment for
confounding factors as well as categorization of
fish intake was different. On the other hand, in the
following Tromsø 6 study with inclusion of individuals
in 2007–2008 from the same geographical area, fatty and
lean fish intake was associatedwith lower TG both inmen
and women (models were only adjusted for age) [10].
The sex differences are not easily explained. One
possible explanation of the observed relationship
between higher fatty fish intake and lower TG in men
but not women could be the higher levels of TG and
absolute fish intake (and thus n-3 LC-PUFA) in men.
The magnitude of the TG reducing effects of EPA+DHA
has been shown to be dose-dependent and higher base-
line TG concentrations predicted a greater response to
EPA+DHA [31]. Indicative of such a relation is the post-
hoc analysis in the current study with associations
between fatty fish intake and lower TG being present
only in men with TG ≥1.7 mmol/L. Although intake of
fish and thus n-3 LC-PUFA were relatively high, and the
level of n-3 LC-PUFA intake in Norwegian women is
higher compared to other populations, the possibility
that the intake of n-3 LC-PUFA was too low to effect
circulating TG in women cannot be excluded. In addi-
tion, hormone-dependent sex differences in lipid meta-
bolism exist and if different biological responses to diet
exist this could affect the results [41]. We had no










































information on hormonal status, and the menopausal
status was not known for all the women. Adjusting for
use of estrogens did not materially affect the results.
Furthermore, the overall dietary pattern and lifestyle
factors related to higher fish intake or type of fish may
be different among men and women and could contri-
bute to an overall better metabolic health. Although
some dietary and lifestyle factors were accounted for in
multivariate analysis, the complex relations of dietary
intake and lifestyle factors with health outcomes are
difficult to account for in observational studies.
Strengths and limitations
The main strengths of the current study include its
large sample size and the available data on clinical and
lifestyle characteristics of the participants.
Importantly, in addition to total fish intake, the cur-
rent FFQ allowed us to also examine type of fish
consumed.
There are limitations that should be highlighted. We
appreciate the problems with measuring true dietary
intake using self-reporting questionnaires. The FFQ
used in the current study has previously been evaluated
against dietary record and fatty acid composition in
plasma phospholipids in other Norwegian populations
[15,16]. Reported fish intake and n-3 LC-PUFA concen-
trations in plasma phospholipids was positively corre-
lated (r = 0.37) [16]. Furthermore, reported fish intake
in our study was similar to that of other Norwegian
studies [11,42]. Thus, the FFQ used in the current
study should estimate fish intake reasonably well,
although the variation between individuals may be con-
siderable and misclassification is possible [16]. The spe-
cies of fish, preparation methods, seasonal variation, and
possible contaminants of fish consumed could not be
examined in the current study and assessment of these
factors will provide additional information regarding
fish–MetS relations. Blood measures in HUSK were
non-fasting. HDL-C seems to be minimally changed to
normal food intake whereas TG is affected by recent
food intake [43]. In the current study, serum TG was
only weakly (rho = 0.05, p < 0.01) inversely associated
with time since last meal. In sensitivity analyses, using a
higher cut-off for defining elevated glucose (≥6.0 instead
of ≥5.0 mmol/L), associations between fish intake and
MetS was not changed. Yet, MetS prevalence estimates
should be interpreted with caution due to risk of mis-
classification and overestimation. Moreover, although
several confounding factors were considered, residual
confounding of unknown or imprecisely measured fac-
tors cannot be excluded.
Conclusion
Fish intake was inversely associated with serum TG;
intake of lean and fatty fish had differential associa-
tions in men and women. The observations of effect
modification by sex and type of fish consumed suggest
that sex differences may be important to explore in
intervention studies with the final aim to individualize
nutritional recommendations.
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